Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study

Renée Ysermans,Matthias H Busch,Joop P Aendekerk,Jan G M C Damoiseaux,Pieter van Paassen

Journal of Translational Autoimmunity（2023）

引用 0|浏览5

暂无评分

摘要

•The addition of low-dose CYC to RTX for remission-induction prolongs relapse-free survival in AAV.•There is no difference in adverse events between RTX-CYC and RTX for remission-induction in AAV.

查看译文

关键词

ANCA,Vasculitis,Rituximab,Cyclophosphamide,Relapse,Outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要